Issues with Intravitreal Administration of Anti-VEGF Drugs
Marc Schargus,1,2 Andreas Frings1,3 1Department of Ophthalmology, Heinrich Heine University, Duesseldorf, Germany; 2Department of Ophthalmology, Asklepios Hospital Nord-Heidberg, Hamburg, Germany; 3Augenarztpraxis Dr. Frings, Nuremberg, GermanyCorrespondence: Marc SchargusDepartment of Ophthalmology...
Saved in:
Main Authors: | Schargus M, Frings A |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/ee8212c44d6c45a1a1c529de79cc6ef3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of the prevalence of silicone oil droplets in the vitreous in patients treated with multiple intravitreal drug injections
by: E. V. Bobykin, et al.
Published: (2021) -
A comparison in precision and accuracy of the conventional syringe to the Suh precision syringe
by: DeLuna D, et al.
Published: (2019) -
Short-Term Non-Infectious Outcomes After a Pars Plana Intravitreal Antibiotic-Steroid Injection of Triamcinolone, Moxifloxacin, and Vancomycin During Cataract Surgery versus a Standard Postoperative Topical Regimen
by: Haq Z, et al.
Published: (2020) -
Prefilled syringes for intravitreal drug delivery
by: Sassalos TM, et al.
Published: (2019) -
Short-Term Changes in Intraocular Pressure After Intravitreal Injection of Bevacizumab for the Treatment of Retinopathy of Prematurity
by: Obata S, et al.
Published: (2019)